Back to Browse Journals » Patient Preference and Adherence » Volume 2

Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers

Authors Carole Decker, Linda Garavalia, Brian Garavalia, John A Spertus

Published 3 June 2008 Volume 2008:2 Pages 167—175

DOI http://dx.doi.org/10.2147/PPA.S3443

Review by Single-blind

Peer reviewer comments 3

Carole Decker1, Linda Garavalia2, Brian Garavalia1, John A Spertus1

1Mid America Heart Institute, Saint Luke’s Hospital, Kansas City, MO, USA; 2Department of Psychology, University of Missouri, Kansas City, MO, USA

Background: Each day, patients make choices whether or not to take their prescribed medications. Previous research has shown that 1 in 7 myocardial infarction (MI) patients discontinued thienopyridines within 1 month of receiving a drug-eluting stent (DES) with serious consequences. This qualitative research study explored in depth the clopidogrel-taking behavior among DES-treated patients who quit taking clopidogrel 1 month after treatment and those who continued therapy.

Methods: Sequential patients from a prospective MI registry who reported discontinuing clopidogrel within 30 days of DES treatment (N = 11) were matched with continuers (N = 11). Both groups underwent detailed qualitative phone interviews. Coding and thematic representation using directed qualitative content analysis by 3 PhD researchers was done.

Results: Patients were 41–77 years old and the majority was Caucasian and male. Multiple barriers were described by discontinuers that were not reported by continuers. The most frequently cited barrier was misunderstanding the intended duration of treatment. Discontinuers also described system weaknesses that contributed to early discontinuance such as gaps in the transition to primary care.

Conclusions: While premature discontinuation of a prescribed therapy is viewed by clinicians as a willful disregard for medical advice, early stopping of clopidogrel is influenced greatly by processes of care and system issues.

Keywords: medication discontinuance, drug-eluting stent post-care, myocardial infarction

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians

Decker C, Garavalia L, Garavalia B, Simon T, Loeb M, Spertus J, Daniel WC

Journal of Multidisciplinary Healthcare 2012, 5:129-135

Published Date: 13 June 2012

Readers of this article also read:

“Keep it simple”: older African Americans’ preferences for a health literacy intervention in HIV management

Gakumo CA, Enah CC, Vance DE, Sahinoglu E, Raper JL

Patient Preference and Adherence 2015, 9:217-223

Published Date: 29 January 2015

Bile salt/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating

Dong F, Xie Y, Qi J, Hu F, Lu Y, Li S, Wu W

International Journal of Nanomedicine 2013, 8:1653-1663

Published Date: 26 April 2013

Public banking of umbilical cord blood or storage in a private bank: testing social and ethical policy in northeastern Italy

Parco S, Vascotto F, Visconti P

Journal of Blood Medicine 2013, 4:23-29

Published Date: 10 April 2013

Hibiscus sabdariffa L., roselle calyx, from ethnobotany to pharmacology

Carvajal-Zarrabal O, Barradas-Dermitz DM, Orta-Flores Z, Hayward-Jones PM, Nolasco-Hipólito C, Aguilar-Uscanga MG, Miranda-Medina A, Bujang KB

Journal of Experimental Pharmacology 2012, 4:25-39

Published Date: 29 February 2012

Organic functionalization of single-walled carbon nanotubes (SWCNTs) with some chemotherapeutic agents as a potential method for drug delivery

Ardeshir Khazaei, Mohammad Navid Soltani Rad, Maryam Kiani Borazjani

International Journal of Nanomedicine 2010, 5:639-645

Published Date: 30 August 2010

Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

Didier Dequanter, Mohammad Shahla, Pascal Paulus, et al

Cancer Management and Research 2010, 2:165-168

Published Date: 28 June 2010

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature

Gaetano Zaccara, Luigi M Specchio

Neuropsychiatric Disease and Treatment 2009, 5:249-259

Published Date: 28 April 2009

Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002

Estelle Lavie, Mélina Fatséas, Jean-Pierre Daulouède, Cécile Denis, Jacques Dubernet, et al

Patient Preference and Adherence 2008, 2:369-378

Published Date: 27 November 2008

Patient recruitment for clinical trials on traditional Chinese medicine: Challenges, barriers, and strategies

Cheng King-Fai, Leung Ping-Chung, Wong Lai-Yi, Fong Yuet-Shim

Patient Preference and Adherence 2008, 2:207-213

Published Date: 11 August 2008